Breaking News Instant updates and real-time market news.

AAPL

Apple

$190.65

2.62 (1.39%)

, SPOT

Spotify

$177.41

1.67 (0.95%)

06:57
07/10/18
07/10
06:57
07/10/18
06:57

Apple narrows Spotify's lead in U.S. music market, FT reports

Apple's (AAPL) increased growth rate in the U.S. is narrowing Spotify's (SPOT) lead in the world's largest music market and shows the tech giant's ability to push its services to users of its devices like the iPhone, the Financial Time reports, citing the services and industry executives. While Spotify still holds a commanding lead globally, Apple had between 21M and 21.5M U.S. subscribers as of last week, while Spotify had 22M to 22.5M. Reference Link

AAPL

Apple

$190.65

2.62 (1.39%)

SPOT

Spotify

$177.41

1.67 (0.95%)

  • 26

    Jul

AAPL Apple
$190.65

2.62 (1.39%)

07/05/18
WBLR
07/05/18
NO CHANGE
WBLR
William Blair sees buying opportunity in 3D sensing names
3D sensing names were weak Tuesday following a preannouncement from BE Semiconductor Industries, William Blair analyst Dmitry Netis tells investors in a research note. The analyst, however, sees "no evidence to draw any parallel to the 3DS supply chain from the Besi preannouncement." He believes "investors are jumping to flabby conclusions, perhaps unjustly, and are overreacting to the news." With respect to Apple's (AAPL) supply chain, Netis continues to believe 3D sensing vendors, Lumentum (LITE) and Viavi (VIAV) mainly, and to lesser extent Finisar (FNSR) and II-VI (IIVI), are set to benefit from Apple's launches this fall. According to supply chain reports, Netis says, the launches will include a 3D sending camera in one low-end LCD phone and two high-end versions of an OLED phone, as well as iPad Pro. He reiterates Outperform ratings on Viavi and Finisar and sees the recent weakness as a buying opportunity.
07/05/18
07/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Fiat Chrysler (FCAU) upgraded to Buy from Hold and Daimler AG (DDAIF) upgraded to Hold from Underperform at Jefferies with analyst Philippe Houchois citing valuation. 2. Danone (DANOY) upgraded to Outperform from Sector Perform at RBC Capital with analyst James Jones saying he now has less "punitive" assumptions about the company's sales growth and capital expenditures as its profits have become less reliant on dairy. 3. Hexcel (HXL) upgraded to Buy from Hold at Canaccord with analyst Ken Herbert stating he believes the acceleration in growth expected in 2018 will continue into 2019. 4. Qorvo (QRVO) upgraded to Overweight from Sector Weight at KeyBanc with analyst Michael McConnell citing healthy China smartphone trends, stabilizing Apple (AAPL) iPhone demand, and greater than expected market share gains in China smartphones. 5. Advanced Energy (AEIS) upgraded to Outperform from Market Perform at Raymond James with analyst Pavel Molchanov saying the company's 9% free cash flow yield has turned the shares into an appealing deep value story, despite slowing organic growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/06/18
LOOP
07/06/18
NO CHANGE
Target $210
LOOP
Buy
Apple price target raised to $210 from $195 at Loop Capital
Loop Capital analyst Ananda Baruah raised his price target on Apple to $210, saying the stock is positioned "net-positively" for the second half of the year with momentum in its Services segment and the launch of a lower priced LCD-based iPhone X expected to be offered in September. The analyst also cites the company's capital return program, with its $100B buyback starting in the June quarter. Baruah kept his Buy rating on Apple.
07/09/18
CHLM
07/09/18
NO CHANGE
Target $85
CHLM
Buy
Lumentum price target lowered to $85 from $90 at Craig-Hallum
Craig-Hallum analyst Richard Shannon lowered his price target for Lumentum (LITE) to $85 from $90, citing inventory overhang from the hard stop on Apple's (AAPL) iPhone X production, and improved module-level yields that drive temporarily lower VCSEL array bare die demand. The analyst reiterates a Buy rating on Lumentum's shares.
SPOT Spotify
$177.41

1.67 (0.95%)

06/27/18
NORD
06/27/18
INITIATION
Target $216
NORD
Buy
Spotify initiated with a Buy at Nordea
Nordea initiated Spotify with a Buy and $216 price target.
07/09/18
LEHM
07/09/18
NO CHANGE
Target $450
LEHM
Overweight
Netflix price target raised to $450 from $370 at Barclays
Barclays analyst Kannan Venkateshwar raised his price target for Netflix to $450 saying he remains positive on the stock despite the 107% rally year-to-date. On a per subscriber basis, Netflix's valuation is not too far off from legacy media businesses, which are growing "significantly slower," Venkateshwar tells investors in a research note titled "What are the key risks to the story?" Further, Netflix "appears even cheap relative to names such as Spotify (SPOT), the analyst contends. His new price target reflects higher subscriber and revenue estimates. Venkateshwar keeps an Overweight rating on Netflix shares.
07/09/18
MKMP
07/09/18
NO CHANGE
Target $200
MKMP
Buy
Spotify best positioned in 'highly investable' music industry, says MKM Partners
MKM Partners analyst Rob Sanderson kept his Buy rating and $200 price target on Spotify, saying the company is "best positioned and has the most interest in advancing a healthy music industry", which has become "highly investable" as its monetization has turned. The analyst further notes that after 20 years of under-investment, the industry can start to rebuild, particularly in recruiting/promoting artists and connecting them with fans. Sanderson believes that Spotify can benefit from "large value creation opportunities" and expects the company to "significantly increase in market share" in the next 5 years.
07/09/18
OPCO
07/09/18
INITIATION
OPCO
Perform
Spotify initiated with a Perform at Oppenheimer
Oppenheimer analyst Jason Helfstein started Spotify Technology with a Perform rating and no price target. The analyst calculates the stock's intrinsic value range at $160-$170 per share or 13-14 time estimated 2019 gross profit. The shares closed the trading day up $1.74 to $177.44. The analyst believes Spotify will benefit from the "secular tailwind of growing digital music streaming adoption" but questions the extent to which it can differentiate its service to maintain market share. Further, Spotify's attempts to improve gross margin by licensing music direct will likely be stymied by labels and premium placement in playlists is "expected," rather than a "paid for" service, Helfstein tells investors in a research note partially titled "A Too Familiar Tune."

TODAY'S FREE FLY STORIES

TSLA

Tesla

$292.51

31.48 (12.06%)

14:55
10/23/18
10/23
14:55
10/23/18
14:55
Hot Stocks
Citron's Left says would be 'wrong' to be short Tesla ahead of Q3 report »

Citron Research's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

IBTX

Independent Bank

$57.55

1.08 (1.91%)

14:54
10/23/18
10/23
14:54
10/23/18
14:54
Recommendations
Independent Bank analyst commentary  »

Independent Bank price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Nov

HXL

Hexcel

14:52
10/23/18
10/23
14:52
10/23/18
14:52
Upgrade
Hexcel rating change  »

Hexcel upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CVE

Cenovus Energy

$8.53

-0.085 (-0.99%)

14:50
10/23/18
10/23
14:50
10/23/18
14:50
Options
Afternoon call buyer in Cenovus Energy »

Afternoon call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:50
10/23/18
10/23
14:50
10/23/18
14:50
General news
Fed's Kaplan reiterated the FOMC should gradual reduce accommodation »

Fed's Kaplan…

TXN

Texas Instruments

$99.84

0.1 (0.10%)

14:49
10/23/18
10/23
14:49
10/23/18
14:49
Options
Texas Instruments options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BIIB

Biogen

$319.27

3.6 (1.14%)

14:47
10/23/18
10/23
14:47
10/23/18
14:47
Recommendations
Biogen analyst commentary  »

Piper a buyer of Biogen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

TSLA

Tesla

$292.44

31.41 (12.03%)

14:44
10/23/18
10/23
14:44
10/23/18
14:44
Hot Stocks
Musk says Tesla will cut some interior configuration options for Model S, X »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

VNQ

Vanguard REIT Index Fund

$77.68

0.64 (0.83%)

14:40
10/23/18
10/23
14:40
10/23/18
14:40
Options
66K Vanguard Real Estate Fund Dec 76 - Jan 72 put spreads trade 71c »

66K Vanguard Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VEEV

Veeva

$88.99

-2.77 (-3.02%)

14:35
10/23/18
10/23
14:35
10/23/18
14:35
Options
Veeva put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
10/23/18
10/23
14:35
10/23/18
14:35
General news
Fed Board minutes showed showed most Banks supported the September 26 rate hike »

Fed Board minutes showed…

TSLA

Tesla

$292.00

30.97 (11.86%)

14:32
10/23/18
10/23
14:32
10/23/18
14:32
Recommendations
Tesla analyst commentary  »

Tesla's moved up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

TTWO

Take-Two

$118.82

-1.69 (-1.40%)

14:30
10/23/18
10/23
14:30
10/23/18
14:30
Periodicals
'Red Dead Redemption 2' development a difficult experience, Kotaku says »

Take-Two's Rockstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

, HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

14:29
10/23/18
10/23
14:29
10/23/18
14:29
Recommendations
Selecta Biosciences, Horizon Pharma analyst commentary  »

Selecta SEL-212 data…

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

BCS

Barclays

$8.60

0.11 (1.30%)

14:20
10/23/18
10/23
14:20
10/23/18
14:20
Options
8-strike put buyers in Barclays Bank ahead of earnings »

8-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SELB

Selecta Biosciences

$8.93

-4.44 (-33.21%)

14:19
10/23/18
10/23
14:19
10/23/18
14:19
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SLG

SL Green Realty

$92.15

0.36 (0.39%)

14:18
10/23/18
10/23
14:18
10/23/18
14:18
Downgrade
SL Green Realty rating change  »

SL Green Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/23/18
10/23
14:17
10/23/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$133.39

-7.945 (-5.62%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Recommendations
Centene analyst commentary  »

Centene should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 14

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$22.65

-1.255 (-5.25%)

14:15
10/23/18
10/23
14:15
10/23/18
14:15
Options
KKR put volume heavy and directionally bearish »

Bearish flow noted in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

SBH

Sally Beauty

$17.78

0.28 (1.60%)

14:09
10/23/18
10/23
14:09
10/23/18
14:09
Hot Stocks
Sally Beauty unveils Sally Beauty Rewards »

"Sally Beauty …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAD

iCAD

$3.10

-0.02 (-0.64%)

14:06
10/23/18
10/23
14:06
10/23/18
14:06
Hot Stocks
iCAD announces new clinical data on the Xoft Electronic Brachytherapy System »

iCAD announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AMD

AMD

$24.73

-0.31 (-1.24%)

14:05
10/23/18
10/23
14:05
10/23/18
14:05
Hot Stocks
AMD, Oracle collaborate on EPYC processor-based offering »

At Oracle's (ORCL)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

UNH

UnitedHealth

$261.89

-0.26 (-0.10%)

14:05
10/23/18
10/23
14:05
10/23/18
14:05
Options
UnitedHealth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.